Need help with B2B Marketing?
Let the smarketers’ team drive your pipeline with data-led campaigns and AI-powered growth strategies.
Pharmaceutical manufacturers and contract developers searching for the right Account-Based Marketing agency for pharma face a narrow, high-stakes shortlist. The right partner must work inside medical, legal and regulatory review, understand that a tech transfer decision runs through quality, supply chain and procurement, and carry published proof in a regulated setting.
This list scores ten agencies on those four things, using public material only. Entries appear alphabetically, not by rank. This list covers agencies CDMOs and pharma manufacturers can hire; for background on how CDMOs run ABM for their own business development, see our guide to how ABM works for CDMOs and CROs.
How We Scored These Account-Based Marketing Agencies for Pharma
| Criterion | Weight | Evidence |
|---|---|---|
| Regulated experience | 30% | Named pharma or device clients |
| Committee coverage | 25% | Quality and procurement reach |
| Review ready process | 25% | Published approval workflow |
| Named proof | 20% | Client name plus metric |
NOTE
Assessed in August 2026 from agency websites, published case studies and partner directory listings. Nothing private was used, outcome numbers appear only where the agency publishes them, and no pharma B2B marketing agency paid to appear on this list. Excluded: agencies with no published B2B case study, agencies whose public work is entirely consumer, and platform vendors with no services arm. The Smarketers publishes this list and is scored against the same rubric, on published proof only.
The ten agencies
The following ten Account-Based Marketing agencies for pharma manufacturing and CDMOs were assessed in August 2026 on public evidence only – no private data, no paid placements.
Abmatic AI
Abmatic AI is an account based marketing platform with services attached, built around website personalisation and account level advertising. It is strongest where the buying signal is digital and the cycle is short. Published work sits almost entirely in software, with no life sciences case study on the site.
Agent3
Agent3, with group creative studio Pretzl, runs insight led ABM for large technology vendors, pairing account intelligence with campaign delivery. It is strongest on data driven account selection at enterprise scale. The published portfolio is concentrated in technology and telecoms, so a manufacturer would be an early regulated client.
Inverta
Inverta designs ABM programmes and trains client teams to run them, with the emphasis on strategy and enablement rather than production. It is strongest when an internal team exists and needs structure around it. Buyers who want studio, media and content execution in one place will need a second supplier.
Ironpaper
Ironpaper is a demand generation agency working with technology and industrial clients on content, paid media and HubSpot delivery. It is strongest on pipeline programmes with a clear conversion path. ABM is one of several service lines rather than the core practice, and no regulated manufacturing case study is published.
Momentum ITSMA
Momentum ITSMA combines the ITSMA research lineage with ABM strategy, account planning and training for global enterprises. It is strongest on executive engagement, account plans and measurement, and it publishes original benchmark research. The model is advisory first, so campaign production usually stays with the client or a second agency.
Strategic ABM
Strategic ABM runs one to one and one to few programmes for enterprise technology vendors, with heavy investment in content built for a single account. It is strongest on deep work across a small account set. Its published clients are technology firms, and no pharmaceutical manufacturing programme appears publicly.
The ABM Agency
The ABM Agency builds account based programmes on intent data and paid orchestration, usually on platforms such as 6sense or Demandbase. It is strongest at turning intent signals into targeted media reach. Pricing is not published, and the available case studies are weighted towards software rather than regulated manufacturing.
The Marketing Practice
The Marketing Practice is a large global B2B agency offering strategy, creative, media, sales enablement and outbound calling in one place, mostly for enterprise technology brands. It is strongest on integrated programmes needing several disciplines at once. Engagement sizes suit enterprise budgets, and published life sciences work is limited.
The Smarketers
The Smarketers is an ITSMA awarded B2B ABM agency for pharma and life sciences (Gold, 2019) and a HubSpot Platinum Solutions Partner. It is strongest at buying group coverage on mid sized budgets; for Eclat Health it delivered 8X growth and 63.6% lower cost per lead. Published health work is revenue cycle, not GMP manufacturing; for broader healthcare and lifesciences ABM coverage including MedTech and health IT, see our ABM agencies for healthcare and lifesciences guide.
Walker Sands
Walker Sands is a B2B agency combining public relations, brand and demand generation, and it publishes original research on search visibility. It is strongest where analyst and press credibility carries the category. The published client base is technology led, and regulated manufacturing does not feature in its named work.
SUAL 1 · CAPTURE THIS
Screenshot of the scoring sheet in Google Sheets: ten agency rows, the four rubric columns, and the evidence link pasted into each cell. Annotate two cells scored zero for missing public evidence. Desktop width, no client data visible.
PROOF POINT
Committee reach is measurable. For Savantis, our team generated more than 150 MQLs from companies with over $500M in revenue, which is the account size where quality and procurement enter the conversation.
How to Choose an Account-Based Marketing Agency for Pharma Manufacturing
Score your own Account-Based Marketing agency for pharma shortlist using the weights above, adjusted to your situation. If approval speed is the bottleneck, push the review criterion to 35% and ask each agency to describe the last claim a regulatory reviewer made them rewrite. If account selection is the bottleneck, weight committee coverage instead – our guide to ABM for manufacturing companies covers account selection frameworks in more depth. Then ask for one reference in a regulated setting and one programme that failed, because how an agency describes a failure tells you more than its polished case studies ever will.
KEY TAKEAWAY
Forrester found in January 2026 that the average business buying decision involves 13 internal stakeholders and 9 external influencers. In regulated manufacturing, buying committee pharma marketing must reach quality, validation and regulatory affairs – the coverage gap most agency proposals ignore.
NOTE
On one life sciences programme we spent the first month rewriting a single positioning paragraph until the regulatory reviewer stopped changing it. Everything afterwards moved quickly, because every asset reused that approved language. Agencies that skip this step spend the same time later, in worse conditions.
Frequently Asked Questions
What Should a CDMO Look for When Selecting an ABM Agency for Pharmaceutical Outsourcing?
A pharma manufacturing business needs an Account-Based Marketing agency with evidence of programmes where quality, regulatory and procurement sat on the buying committee, plus a content process that survives medical and legal review. Ask for one named client in a regulated setting and how long an asset took to clear, or book an ABM fit review to apply this rubric to your own shortlist.
Can a Generalist B2B Agency Run ABM for Pharma Manufacturing?
They can, when the client supplies the regulatory guardrails. The risk is time. An agency that has never worked inside a review spends two quarters learning what it cannot claim, which is expensive when the cycle already runs past a year.
How Long Before a Pharma Manufacturing ABM Programme Shows Pipeline?
For pharma manufacturing and CDMO ABM programmes, expect engagement signals within one quarter and qualified pipeline in two to three quarters. Revenue takes longer because tech transfer decisions pass through multiple regulatory and commercial approvals. Agree in advance which leading indicators count as progress and review them monthly – our complete ABM guide for life sciences covers measurement frameworks in full.
Should a Pharma Manufacturer Choose a Specialist ABM Agency or a Large Integrated Agency?
Choose the specialist when your constraint is approval and claim substantiation. Choose the larger agency when your constraint is breadth, because a launch needs media, creative and enablement running together. Few agencies do both, so decide which constraint binds you.
Enoch Pakanati
CEO
